Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katrina S Pedersen

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2023
A Pilot Study of Paricalcitol plus Nanoliposomal Irinotecan and 5-FU/LV in Advanced Pancreatic Cancer Patients after Progression on Gemcitabine-Based TherapyPatrick M Grierson, Rama Suresh, Benjamin Tan, et al.
Journal of Gastrointestinal Oncology|January 5, 2018
Pacritinib to inhibit JAK/STAT signaling in refractory metastatic colon and rectal cancerThomas Regenbogen, Ling Chen, Kathryn Trinkaus, et al.
Tomography (Ann Arbor, Mich.)|November 22, 2022
FDG-PET/MRI for Nonoperative Management of Rectal Cancer: A Prospective Pilot StudySemra Ince, Malak Itani, Lauren E Henke, et al.
Diseases of the Colon and Rectum|January 6, 2022
Total Neoadjuvant Therapy With Short-Course Radiation: US Experience of a Neoadjuvant Rectal Cancer TherapyWilliam C Chapman, Hyun Kim, Philip Bauer, et al.
The Oncologist|November 25, 2022
Phase Ib Study of Ulixertinib Plus Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic AdenocarcinomaPatrick M Grierson, Benjamin Tan, Katrina S Pedersen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2021
ZEBRA: A Multicenter Phase II Study of Pembrolizumab in Patients with Advanced Small-Bowel AdenocarcinomaKatrina S Pedersen, Nathan R Foster, Michael J Overman, et al.
Communications Medicine|July 20, 2022
Hybrid-control arm construction using historical trial data for an early-phase, randomized controlled trial in metastatic colorectal cancerChen Li, Ana Ferro, Shivani K Mhatre, et al.
JAMA Oncology|May 30, 2020
FOLFIRINOX for the Treatment of Advanced Gastroesophageal Cancers: A Phase 2 Nonrandomized Clinical TrialHaeseong Park, Ramon U Jin, Andrea Wang-Gillam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2022
Safety and Tolerability of MEDI0562, an OX40 Agonist mAb, in Combination with Durvalumab or Tremelimumab in Adult Patients with Advanced Solid TumorsJonathan W Goldman, Sarina A Piha-Paul, Brendan Curti, et al.
International Journal of Radiation Oncology, Biology, Physics|October 15, 2021
Clinical Complete Response in Patients With Rectal Adenocarcinoma Treated With Short-Course Radiation Therapy and Nonoperative ManagementRe-I Chin, Amit Roy, Katrina S Pedersen, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2023
A Pilot Study of Paricalcitol plus Nanoliposomal Irinotecan and 5-FU/LV in Advanced Pancreatic Cancer Patients after Progression on Gemcitabine-Based TherapyPatrick M Grierson, Rama Suresh, Benjamin Tan, et al.
Journal of Gastrointestinal Oncology|January 5, 2018
Pacritinib to inhibit JAK/STAT signaling in refractory metastatic colon and rectal cancerThomas Regenbogen, Ling Chen, Kathryn Trinkaus, et al.
Tomography (Ann Arbor, Mich.)|November 22, 2022
FDG-PET/MRI for Nonoperative Management of Rectal Cancer: A Prospective Pilot StudySemra Ince, Malak Itani, Lauren E Henke, et al.
Diseases of the Colon and Rectum|January 6, 2022
Total Neoadjuvant Therapy With Short-Course Radiation: US Experience of a Neoadjuvant Rectal Cancer TherapyWilliam C Chapman, Hyun Kim, Philip Bauer, et al.
The Oncologist|November 25, 2022
Phase Ib Study of Ulixertinib Plus Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic AdenocarcinomaPatrick M Grierson, Benjamin Tan, Katrina S Pedersen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2021
ZEBRA: A Multicenter Phase II Study of Pembrolizumab in Patients with Advanced Small-Bowel AdenocarcinomaKatrina S Pedersen, Nathan R Foster, Michael J Overman, et al.
Communications Medicine|July 20, 2022
Hybrid-control arm construction using historical trial data for an early-phase, randomized controlled trial in metastatic colorectal cancerChen Li, Ana Ferro, Shivani K Mhatre, et al.
JAMA Oncology|May 30, 2020
FOLFIRINOX for the Treatment of Advanced Gastroesophageal Cancers: A Phase 2 Nonrandomized Clinical TrialHaeseong Park, Ramon U Jin, Andrea Wang-Gillam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2022
Safety and Tolerability of MEDI0562, an OX40 Agonist mAb, in Combination with Durvalumab or Tremelimumab in Adult Patients with Advanced Solid TumorsJonathan W Goldman, Sarina A Piha-Paul, Brendan Curti, et al.
International Journal of Radiation Oncology, Biology, Physics|October 15, 2021
Clinical Complete Response in Patients With Rectal Adenocarcinoma Treated With Short-Course Radiation Therapy and Nonoperative ManagementRe-I Chin, Amit Roy, Katrina S Pedersen, et al.
Pageof 3